XRTX PRESS-RELEASE SEC Filing Analysis

Latest settled — T+5d ⚠ clustered

XRTX ▲ +14.93% at T+5d

SHORT call ✗ call lost -14.93% · α vs SPY -15.64% · entry $2.01 → $2.31

Next anchor: T+20d in 2d

Last close $2.18 (close Jun 8) · -8.46% from $2.01 entry (call sign-flipped)

Entry anchored
May 13, 11:04 AM ET
via Databento tick

T+1d

+28.86%

call -28.86% · α -30.08%

$2.59

settled 26d ago

T+5d

+14.93%

call -14.93% · α -15.64%

$2.31

settled 20d ago

T+20d

—

call — · α —

—

in 2d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

XORTX Therapeutics priced a public offering of ~2.66M shares at $1.88/share for $5M gross proceeds, representing massive dilution (~170% of pre-offering market cap). The offering is expected to close May 15, 2026.

Key Financial Metrics

Deal Value

$5.0M

Actionable Insight

Immediate selling pressure expected as the offering significantly dilutes existing holders. Watch for price action around the May 15 close and potential follow-on volatility. The company's cash runway improves but at substantial near-term cost to shareholders.

Key Facts

Priced public offering of 2,659,574 common shares or pre-funded warrants at $1.88/share
Gross proceeds of $5 million
Offering expected to close May 15, 2026
E.F. Hutton & Co. acting as exclusive placement agent
Market cap prior to offering approximately $3 million

Financial Impact

Issuance of ~2.66M shares against ~1.6M shares outstanding (estimated) results in ~62% dilution (assuming all common shares); pre-funded warrants add further potential dilution.

dilutionshare count

Risk Factors

Massive dilution depresses per-share valuation
Potential difficulty in selling the offering at the stated price
No guarantee of closing if conditions not met

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Analyst Consensus

80% bullish (5 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3294730

12 reports for XRTX

T+1T+5T+20T+60

60% Hit rate 3 of 5 directional calls best @ T+5▲ +23.96%Apr 13, 2026

Filters

Reports for XRTX — sortable, filterable
	Type				Now
May 19, 2026 21d ago	6-K / PRESS-RELEASE BEARISH ★ 6/10	$2.32 $2.40	▼ −3.45%	▼ −1.15%	$2.18 (+6.03%)
May 15, 2026 25d ago	424B4 BEARISH ★ 7/10	$2.59 $2.18	▲ +15.83%	▲ +16.79%	$2.18 (+15.83%)
May 14, 2026 26d ago	6-K BEARISH ★ 7/10	$2.01 $2.31	▼ −14.93%	▼ −15.64%	$2.18 (−8.46%)
May 14, 2026 26d ago	Press Release BEARISH ★ 6/10	$2.01 $2.31	▼ −14.93%	▼ −15.64%	$2.18 (−8.46%)
Apr 21, 2026 7w ago	6-K NEUTRAL ★ 5/10	$2.69 $2.77	▲ +2.97%	▲ +1.89%	$2.18 (−18.96%)
Apr 16, 2026 7w ago	6-K BULLISH ★ 7/10	$2.44 $2.77	▲ +13.52%	▲ +12.54%	$2.18 (−10.66%)
Apr 13, 2026 8w ago	Press Release BULLISH ★ 7/10	$2.17 $2.69	▲ +23.96%	▲ +22.57%	$2.18 (+0.46%)
Mar 27, 2026 10w ago	6-K NEUTRAL ★ 3/10	$1.90 $2.32	▲ +22.43%	▲ +18.57%	$2.18 (+15.04%)
Mar 27, 2026 10w ago	6-K NEUTRAL ★ 3/10	$1.90 $2.32	▲ +22.43%	▲ +18.57%	$2.18 (+15.04%)
Mar 26, 2026 10w ago	Press Release NEUTRAL ★ 4/10	$1.90 $2.32	▲ +22.43%	▲ +18.57%	$2.18 (+15.04%)

US Market Status

Market Closed — Opens in 6h 54m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access